Get Free Sample link @ https://www.omrglobal.com/request-sample/benign-prostatic-hyperplasia-treatment-market
The rising frequency of benign prostatic hyperplasia is the key factor, which is a major driver of this market growth. Besides, public awareness, the government initiatives, an increase in health budget are also driving the global benign prostatic hyperplasia market growth. Researchers found that there is an alarmingly increasing rate of benign prostatic hyperplasia among the middle-aged and old-aged men. Since people are less aware of the BHP, many country's governments are launching many awareness campaigns to spread awareness about BPH symptoms and treatment. For instance, the US health advocate and health authorities conduct prostate health awareness campaign the “National Prostate Health Month” every year in September, to educate the people about the risk and treatment, that are associates with benign prostatic hyperplasia.
A full report of Global Benign Prostatic Hyperplasia Treatment Market available @ https://www.omrglobal.com/industry-reports/benign-prostatic-hyperplasia-treatment-market
• Market Coverage
• Market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Benign Prostatic Hyperplasia Treatment Market by Treatment
o Medications
o Alpha-blockers
o 5 Alpha reductase inhibitor (ARIs)
o Phosphodiesterase-5 Enzyme Inhibitor
o Others
o Minimally Invasive Procedures
o Transurethral Resection of the Prostate (TURP)
o Transurethral Incision of the Prostate (TUIP)
o Transurethral Microwave Thermotherapy (TUMT)
o Transurethral Needle Ablation (TUNA)
o Laser Therapy
o Ablative procedures
o Enucleation procedures
o Others (Surgery, Prothetic urethral lift, Embolization)
Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Abbott Laboratories
o Allergan, Inc.
o Astellas Pharma, Inc.
o Boehringer Ingelheim GmbH
o Boston Scientific Corp.
o Camber Pharmaceuticals, Inc.
o Coloplast A/S
o Daiichi Sankyo Co., Ltd.
o Eli Lilly &Co.
o Endo International PLC
o GlaxoSmithKline PLC
o Karl Storz GmbH& Co.Kg
o Lumenis, Ltd.
o Merck & Co., Inc.
o Nymox Pharmaceutical Corp.
o Olympus Corp.
o Pfizer, Inc.
o ProArc Medical, Ltd.
o Sanofi S.A.
o Sophiris Bio Corp.
o Sun Pharmaceutical Industries, Ltd.
o Synthon B.V.
o Teva Pharmaceutical Industries, Ltd.
o Urologix, Inc.
o Veru, Inc.
The Report Covers
• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global benign prostatic hyperplasia treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/industry-reports/benign-prostatic-hyperplasia-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404